At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 100 enrolled
Drug / intervention
Fluoresceindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
In Brief
A Early Phase 1 clinical trial evaluating Fluorescein for Endometrial Cancer. Completed, enrolled 100 participants across 1 site.
Detailed Summary
To determine if Fluorescein systemic injection during hysterectomy procedure can be useful in revealing the depth of endometrial cancer invasion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEndometrial Cancer
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 2013
Enrollment StartSep 2014
Primary CompletionOct 2019
Study CompletionJun 2021
TodayJul 2026
First PostedNov 8, 2013
Enrollment StartSep 1, 2014
Primary CompletionOct 2, 2019
Study CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 12.7 years ago
Interventions
Fluoresceindrug